Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-061423
Filing Date
2019-12-19
Accepted
2019-12-19 21:06:03
Documents
1
Period of Report
2019-12-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 18639
  Complete submission text file 0001209191-19-061423.txt   20035
Mailing Address C/O INFINITY PHARMACEUTICALS, INC. 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address
Babler Martin (Reporting) CIK: 0001435618 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38653 | Film No.: 191297527

Mailing Address 400 EAST JAMIE COURT, SUITE 302 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT, SUITE 302 SOUTH SAN FRANCISCO CA 94080 (650) 416-7700
Principia Biopharma Inc. (Issuer) CIK: 0001510487 (see all company filings)

EIN.: 263487603 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations